Developer docs
API playgroundTry for free, no card

Search company profiles

HerKare

Full company profile

uuid00091uj

Namestring
HerKare
Legal namestring
SynergenX Health Holdings, LLC
Websiteurl
herkare.com
Company typeenum
Private
Founded yearint
2009
Descriptiontext

HerKare is a Texas-based women's healthcare clinic network founded in 2009 and operated under parent company SynergenX Health Holdings, LLC. The company specializes in bioidentical hormone replacement therapy (HRT), addressing symptoms of perimenopause, menopause, thyroid deficiency, and other hormonal imbalances in women, with additional offerings in medically guided weight loss (including GLP-1 medications such as semaglutide and tirzepatide), peptide therapy, PT-141 for sexual health, glutathione injections, and at-home sleep testing. Its clinical approach combines a 65+ biomarker hormone panel with lipid and metabolic panels, Autonomic Nervous System (ANS) testing, and InBody body composition scans to support individualized treatment planning, with bioidentical hormones delivered via pills, topical creams, pellets, injections, and suppositories.

The company operates five clinic locations in Texas — four in the Dallas-Fort Worth metroplex (Frisco, Fort Worth, Mansfield, Southlake) and one in The Woodlands — supplemented by telehealth visits and the SynergenX mobile app for iOS and Android, which enables appointment booking, digital check-in, lab results review, supplement ordering, telemedicine, and medication reminders. HerKare accepts 12+ major insurance plans and offers self-pay options (including a $99 discounted hormone testing panel), with HSA/FSA eligibility. The company is led by CEO Wayne Wilson and is currently transitioning to the SynergenX brand alongside Low T Centers over a roughly 12-month horizon, consolidating women's and men's hormone therapy under a single national brand identity.

Revenue is generated through recurring insurance-reimbursed and self-pay clinical visits, ongoing HRT prescriptions, weight loss program enrollment, and ancillary wellness services. The business model combines subscription-like recurring revenue from long-term HRT patients with one-time diagnostic and consult fees. The company is privately held with no disclosed funding rounds, revenue figures, or external PE/VC ownership signals in the available source data.

Short descriptiontext

HerKare is a Texas-based women's healthcare clinic network operating 5 locations that delivers bioidentical hormone replacement therapy, medically guided weight loss programs including GLP-1 medications, and comprehensive women's wellness services targeting perimenopause, menopause, and hormonal imbalances.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersSouthlake, United States
HQ citystring
Southlake
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices6 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
women's hormone therapy, bioidentical hormone replacement, women's wellness clinics, medical weight loss programs, menopause treatment services
Industry3 codes
PRIMARYHLAKAJAL
Gynecology (General Non-Obstetric Care)
SECONDARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLALAHAJ
Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)
NAICS code1 code
  • Other Ambulatory Health Care Services6219
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Women's Hormone Therapy and Wellness Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Insurance-Covered Healthcare Services
TypeSubscription Recurring
Description

HerKare accepts major insurance plans including Aetna, Blue Cross Blue Shield, Cigna PPO, UnitedHealthcare, GEHA, Medical Mutual of Ohio, Meritain Health, APWU Health Plan, HealthPartners of Minnesota, and others. Services covered may include HRT, peptide therapy, GLP-1 weight loss medications, and lab monitoring.

herkare.com
2Self-Pay Services
TypeOne Time License
Description

Self-pay options available for patients without insurance coverage, including discounted hormone testing at $99 (reduced from $200)

herkare.com
3Hormone Replacement Therapy
TypeSubscription Recurring
Description

Ongoing HRT treatments including estrogen, progesterone, and testosterone therapy through various delivery methods (pills, creams, pellets, injections, suppositories)

herkare.com
4Weight Loss Programs
TypeSubscription Recurring
Description

Medically guided weight loss programs including GLP-1 medications (Semaglutide, Tirzepatide), oral medications, and combination programs

herkare.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details2 tiers
1Comprehensive Hormone Testing - Insurance or Self-Pay
ModelHybridBilling cadencePay-as-you-go
Notes

$99 self-pay flat fee (discounted from $200) or insurance specialist copay. Limited-time promotional offer for new patients.

herkare.com
2Insurance-Covered Services
ModelSubscriptionBilling cadenceMonthly
Notes

Coverage varies by plan. Accepted insurers include Aetna, Blue Cross Blue Shield, Cigna PPO & Health Plans, UnitedHealthcare, GEHA Standard Option, Medical Mutual of Ohio, Meritain Health, APWU Health Plan, HealthPartners of Minnesota, Gravie, PHCS Savility, and Cornerstone Preferred Resources.

herkare.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

HerKare operates a network of women's healthcare clinics delivering bioidentical hormone replacement therapy (estrogen, progesterone, testosterone) through multiple delivery methods (pills, creams, pellets, injections, suppositories), medically guided weight loss programs featuring GLP-1 medications, and comprehensive diagnostic hormone testing. The company also offers ancillary women's wellness services including peptide therapy, thyroid treatment, PT-141 for sexual health, and glutathione injections, delivered through 5 Texas clinic locations and telehealth channels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 80% of women experience hormonal imbalance
Product overview1 text field

HerKare is a women's healthcare clinic network providing specialized hormone health and wellness services across Texas. The company operates a platform-plus-services model offering bioidentical hormone replacement therapy (including estrogen, progesterone, and testosterone replacement in pills, creams, pellets, and injections), medically guided weight loss programs (featuring GLP-1 medications like semaglutide and tirzepatide in both injectable and oral dissolvable forms), comprehensive diagnostic testing (65+ biomarker hormone panels, ANS testing, InBody scans), women's wellness services (peptide therapy, menopause care, vitamin optimization, glutathione injections), and FDA-approved treatments like PT-141 for sexual health. Services are delivered through 5 Texas clinic locations and a proprietary SynergenX mobile app enabling appointment booking, telehealth visits, and patient engagement. The company is transitioning to the SynergenX brand while maintaining its focus on personalized, medically guided women's healthcare.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeOthersAnnounced on2026-06-12
Description

HerKare is transitioning to the SynergenX brand. Over the next year, HerKare clinics along with Low T Centers across the country will slowly transition to the SynergenX brand. The transition reflects continued growth of a company focused on personalized, medically guided care. HerKare and Low T Centers operate under the same parent company, SynergenX Health Holdings, LLC.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Telehealth platform focused on menopause and perimenopause care, providing HRT prescriptions and ongoing virtual care — overlaps HerKare's core menopause and hormonal imbalance offerings.

2Ro
TypeBroad incumbent
Description

Multi-specialty telehealth platform offering HRT, weight loss (including GLP-1s), and women's health services — competes on overlapping offerings as a broader DTC health incumbent.

TypeEmerging player
Description

Virtual women's and family health platform covering hormonal health, fertility, and perimenopause — adjacent competitor in the women's virtual care category.

TypeDirect peer
Description

Women's menopause care platform combining virtual clinician visits with education and community — serves the same perimenopause/menopause patient segment as HerKare.

TypeDirect peer
Description

Women's health clinic network offering in-person and virtual care including gynecology and hormonal care — comparable as a clinic-plus-virtual women's health provider.

TypeDirect peer
Description

Direct-to-consumer women's hormone therapy provider offering bioidentical HRT and telehealth consultations — closely parallels HerKare's bioidentical hormone focus and prescription delivery model.

TypeEmerging player
Description

Functional medicine practice focusing on root-cause diagnosis and complex women's health conditions including hormones — overlaps with HerKare's diagnostic-heavy, personalized approach.

TypeDirect peer
Description

Virtual-first specialty clinic for women in perimenopause and menopause, offering HRT, weight management, and telehealth visits — directly competes with HerKare for the same patient demographic and service lines.

TypeDirect peer
Description

Telehealth platform specializing in menopause treatment with prescription and OTC products — directly competes with HerKare's menopause and hormonal health services.

TypeBroad incumbent
Description

Public telehealth company offering broad women's health services including hormone and weight loss treatments — broad incumbent competing for the same digitally-native patients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

HerKare

Women's Hormone Therapy and Wellness Servicesherkare.com

HerKare is a Texas-based women's healthcare clinic network operating 5 locations that delivers bioidentical hormone replacement therapy, medically guided weight loss programs including GLP-1 medications, and comprehensive women's wellness services targeting perimenopause, menopause, and hormonal imbalances.

What HerKare does

HerKare is a Texas-based women's healthcare clinic network founded in 2009 and operated under parent company SynergenX Health Holdings, LLC. The company specializes in bioidentical hormone replacement therapy (HRT), addressing symptoms of perimenopause, menopause, thyroid deficiency, and other hormonal imbalances in women, with additional offerings in medically guided weight loss (including GLP-1 medications such as semaglutide and tirzepatide), peptide therapy, PT-141 for sexual health, glutathione injections, and at-home sleep testing. Its clinical approach combines a 65+ biomarker hormone panel with lipid and metabolic panels, Autonomic Nervous System (ANS) testing, and InBody body composition scans to support individualized treatment planning, with bioidentical hormones delivered via pills, topical creams, pellets, injections, and suppositories.

The company operates five clinic locations in Texas — four in the Dallas-Fort Worth metroplex (Frisco, Fort Worth, Mansfield, Southlake) and one in The Woodlands — supplemented by telehealth visits and the SynergenX mobile app for iOS and Android, which enables appointment booking, digital check-in, lab results review, supplement ordering, telemedicine, and medication reminders. HerKare accepts 12+ major insurance plans and offers self-pay options (including a $99 discounted hormone testing panel), with HSA/FSA eligibility. The company is led by CEO Wayne Wilson and is currently transitioning to the SynergenX brand alongside Low T Centers over a roughly 12-month horizon, consolidating women's and men's hormone therapy under a single national brand identity.

Revenue is generated through recurring insurance-reimbursed and self-pay clinical visits, ongoing HRT prescriptions, weight loss program enrollment, and ancillary wellness services. The business model combines subscription-like recurring revenue from long-term HRT patients with one-time diagnostic and consult fees. The company is privately held with no disclosed funding rounds, revenue figures, or external PE/VC ownership signals in the available source data.

HerKare firmographics

Firmographics
Name
HerKare
Legal name
SynergenX Health Holdings, LLC
Website
https://herkare.com
Company type
Private
Founded year
2009
Operating status
Operating
Headcount range
11–50 employees
Short description
HerKare is a Texas-based women's healthcare clinic network operating 5 locations that delivers bioidentical hormone replacement therapy, medically guided weight loss programs including GLP-1 medications, and comprehensive women's wellness services targeting perimenopause, menopause, and hormonal imbalances.
Ownership category
akta.pro rank

HerKare industry classification

Industry
Product category
Women's Hormone Therapy and Wellness Services
NAICS
Other Ambulatory Health Care Services (6219)
SIC
Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAKAJAL
Gynecology (General Non-Obstetric Care)
SECONDARYHLAFAJAA
Obstetrics & Gynecology (OB/GYN) Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers
SECONDARYHLALAHAJ
Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support)
Healthcare & Life Sciences/Telehealth Platforms/Women’s & Family Health Telehealth Platforms (fertility, pregnancy, pediatrics)

Keywords

  • Women's hormone therapy
  • Bioidentical hormone replacement
  • Women's wellness clinics
  • Medical weight loss programs
  • Menopause treatment services

Where HerKare is headquartered

Location

Headquarters

HQ city
Southlake
HQ country
United States
HQ region
North America

Offices6 records

Markets served

HerKare business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Insurance-Covered Healthcare Services: HerKare accepts major insurance plans including Aetna, Blue Cross Blue Shield, Cigna PPO, UnitedHealthcare, GEHA, Medical Mutual of Ohio, Meritain Health, APWU Health Plan, HealthPartners of Minnesota, and others. Services covered may include HRT, peptide therapy, GLP-1 weight loss medications, and lab monitoring.
  2. Self-Pay Services: Self-pay options available for patients without insurance coverage, including discounted hormone testing at $99 (reduced from $200)
  3. Hormone Replacement Therapy: Ongoing HRT treatments including estrogen, progesterone, and testosterone therapy through various delivery methods (pills, creams, pellets, injections, suppositories)
  4. Weight Loss Programs: Medically guided weight loss programs including GLP-1 medications (Semaglutide, Tirzepatide), oral medications, and combination programs

Pricing tiers

ModelBillingPrice
HybridPay-as-you-goComprehensive Hormone Testing - Insurance or Self-Pay
SubscriptionMonthlyInsurance-Covered Services

Go-to-market motion1 record

Distribution channels4 records

Marketing channels4 records

HerKare product offering

Product offering

Core offering

HerKare operates a network of women's healthcare clinics delivering bioidentical hormone replacement therapy (estrogen, progesterone, testosterone) through multiple delivery methods (pills, creams, pellets, injections, suppositories), medically guided weight loss programs featuring GLP-1 medications, and comprehensive diagnostic hormone testing. The company also offers ancillary women's wellness services including peptide therapy, thyroid treatment, PT-141 for sexual health, and glutathione injections, delivered through 5 Texas clinic locations and telehealth channels.

Product overview

HerKare is a women's healthcare clinic network providing specialized hormone health and wellness services across Texas. The company operates a platform-plus-services model offering bioidentical hormone replacement therapy (including estrogen, progesterone, and testosterone replacement in pills, creams, pellets, and injections), medically guided weight loss programs (featuring GLP-1 medications like semaglutide and tirzepatide in both injectable and oral dissolvable forms), comprehensive diagnostic testing (65+ biomarker hormone panels, ANS testing, InBody scans), women's wellness services (peptide therapy, menopause care, vitamin optimization, glutathione injections), and FDA-approved treatments like PT-141 for sexual health. Services are delivered through 5 Texas clinic locations and a proprietary SynergenX mobile app enabling appointment booking, telehealth visits, and patient engagement. The company is transitioning to the SynergenX brand while maintaining its focus on personalized, medically guided women's healthcare.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • 80% of women experience hormonal imbalance

Companies that use HerKare

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

HerKare technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

HerKare partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • SynergenXcoreOthers · 12 June 2026HerKare is transitioning to the SynergenX brand. Over the next year, HerKare clinics along with Low T Centers across the country will slowly transition to the SynergenX brand. The transition reflects continued growth of a company focused on personalized, medically guided care. HerKare and Low T Centers operate under the same parent company, SynergenX Health Holdings, LLC.

Scale indicators2 records

Recent moves7 records

Expansion highlights5 records

HerKare competitors and assessment

Company assessment

Direct peers

  • Evernow: Telehealth platform focused on menopause and perimenopause care, providing HRT prescriptions and ongoing virtual care — overlaps HerKare's core menopause and hormonal imbalance offerings.
  • Elektra Health: Women's menopause care platform combining virtual clinician visits with education and community — serves the same perimenopause/menopause patient segment as HerKare.
  • Tia: Women's health clinic network offering in-person and virtual care including gynecology and hormonal care — comparable as a clinic-plus-virtual women's health provider.
  • Winona: Direct-to-consumer women's hormone therapy provider offering bioidentical HRT and telehealth consultations — closely parallels HerKare's bioidentical hormone focus and prescription delivery model.
  • Midi Health: Virtual-first specialty clinic for women in perimenopause and menopause, offering HRT, weight management, and telehealth visits — directly competes with HerKare for the same patient demographic and service lines.
  • Alloy Women's Health: Telehealth platform specializing in menopause treatment with prescription and OTC products — directly competes with HerKare's menopause and hormonal health services.

Broad incumbents

  • Ro: Multi-specialty telehealth platform offering HRT, weight loss (including GLP-1s), and women's health services — competes on overlapping offerings as a broader DTC health incumbent.
  • Hims & Hers Health: Public telehealth company offering broad women's health services including hormone and weight loss treatments — broad incumbent competing for the same digitally-native patients.

Emerging players

  • Maven Clinic: Virtual women's and family health platform covering hormonal health, fertility, and perimenopause — adjacent competitor in the women's virtual care category.
  • Parsley Health: Functional medicine practice focusing on root-cause diagnosis and complex women's health conditions including hormones — overlaps with HerKare's diagnostic-heavy, personalized approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

HerKare social profiles

Digital presence

HerKare compliance and trust

Trust signal

Compliance1 record

HerKare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

HerKare leadership team

Management profile

Number of profiles

Profiles4 records

HerKare funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

HerKare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about HerKare

What does HerKare do?

HerKare operates a network of women's healthcare clinics delivering bioidentical hormone replacement therapy (estrogen, progesterone, testosterone) through multiple delivery methods (pills, creams, pellets, injections, suppositories), medically guided weight loss programs featuring GLP-1 medications, and comprehensive diagnostic hormone testing. The company also offers ancillary women's wellness services including peptide therapy, thyroid treatment, PT-141 for sexual health, and glutathione injections, delivered through 5 Texas clinic locations and telehealth channels.

Is HerKare a public or private company?

HerKare is a private company. It is classified as corporate owned and is currently operating.

When was HerKare founded?

HerKare was founded in 2009. It employs 11 to 50 people.

Where is HerKare based?

HerKare is headquartered in Southlake, United States, in the North America region.

How does HerKare make money?

Four revenue lines are on record. Insurance-Covered Healthcare Services are the primary driver. The others are self-Pay Services, hormone Replacement Therapy and weight Loss Programs.

Who are HerKare's main competitors?

Direct peers on record are Evernow, Elektra Health, Tia, Winona, Midi Health and Alloy Women's Health. Broad incumbents are Ro and Hims & Hers Health. Emerging players are Maven Clinic and Parsley Health.

Does HerKare have an API?

No public API is recorded for HerKare.

What industry is HerKare in?

HerKare's product category is Women's Hormone Therapy and Wellness Services. Its primary akta.pro industry code is HLAKAJAL, Gynecology (General Non-Obstetric Care), with a secondary code of HLAFAJAA, Obstetrics & Gynecology (OB/GYN) Clinics. Its NAICS code is 6219 and its SIC code is 8011.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
YahooSynergenX, Low T Center and HerKare Clinics Unite Under the SynergenX BrandSynergenX announced that its Low T Center and HerKare clinics will transition under a unified brand identity over the coming year. The company, founded in 2016 by Wayne Wilson, will roll out the change gradually across clinics, digital platforms, and marketing materials. The transition reflects its mission of personalized, medically guided care for men and women.Business Wire BlogSynergenX, Low T Center and HerKare Clinics Unite Under the SynergenX BrandSynergenX announced that its Low T Center and HerKare clinics will transition under a unified SynergenX brand over the coming year. The transition includes a new logo and updated marketing materials, reflecting the company's commitment to personalized, medically guided care for men and women.PR NewswireHerKare Expands with New Premier Location in Southlake, TexasHerKare, a women\'s wellness clinic specializing in hormone imbalance treatment, has relocated its Southlake, Texas headquarters to a larger 11,000 square foot stand-alone building at 1210 N. Carroll Avenue. The expansion enables the addition of gynecology services and a new medical provider, Dr. Carolyn Moyers, while the company operates six total locations across the Dallas-Fort Worth and Houston areas. The move marks the company\'s growth from its original single Southlake location since its founding in 2013.PR NewswireHerKare Adds Two More Centers As Demand Grows For Women's Healthcare In DFWHerKare has opened a new women's healthcare center in Fort Worth, Texas, marking its fourth location in the Dallas-Fort Worth area. This expansion is part of the company's strategy to meet growing demand for women's wellness and hormonal imbalance treatments across Texas.